A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
Gary L. Davis, David R. Nelson, Norah Terrault, Timothy L. Pruett, Thomas D. Schiano, Courtney V. Fletcher, Christine V. Sapan, Laura N. Riser, Yufeng Li, Richard J. Whitley, John W. Grann
Dive into the research topics of 'A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients'. Together they form a unique fingerprint.